This is not the latest version of this item. The latest version can be found here.
The Use of Microfluidic Platforms to Probe the Mechanism of Cancer Cell Extravasation
Name
adhm.201901410.pdf
Description
Published version
Size
1.76 MB
Format
Adobe PDF
Checksum (MD5)
201bf259a5eb317d01b7d4a2506bd22b
Author(s)
Coughlin, Mark F
Kamm, Roger D
Date Issued
2020
Journal
Advanced Healthcare Materials
Publisher
Wiley
Version
Final published version
Abstract
© 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim Powerful experimental tools have contributed a wealth of novel insight into cancer etiology from the organ to the subcellular levels. However, these advances in understanding have outpaced improvements in clinical outcomes. One possible reason for this shortcoming is the reliance on animal models that do not fully replicate human physiology. An alternative in vitro approach that has recently emerged features engineered microfluidic platforms to investigate cancer progression. These devices allow precise control over cellular components, extracellular constituents, and physical forces, while facilitating detailed microscopic analysis of the metastatic process. This review focuses on the recent use of microfluidic platforms to investigate the mechanism of cancer cell extravasation.
Terms of Use
Creative Commons Attribution-NonCommercial-NoDerivs License
Persistent DSpace Link
DOI of Published Version
10.1002/ADHM.201901410
